Advertisement

Therapeutic Application of Adrenomedullin

  • Toshio Nishikimi
  • Noritoshi Nagaya
  • Kenji Kangawa
  • Hiroaki Matsuoka
Part of the Basic Science for the Cardiologist book series (BASC, volume 19)

Keywords

Knockout Mouse Pulmonary Hypertension Ischemic Renal Injury Septic Shock Model Pulmonary Hypertension Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ebara T, Miura K, Okumura M, Matsuura T, Kim S, Yukimura T, Iwao H. (1994) Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol. 263:69–73.CrossRefPubMedGoogle Scholar
  2. Hirata Y, Hayakawa H, Suzuki Y, Suzuki E, Ikenouchi H, Kohmoto O, Kimura K, Kitamura K, Eto T, Kangawa K, Matsuo H, Omata M (1995) Mechanisms of adrenomedullin-inducedvasodilation in the rat kidney. Hypertension 25:790–795PubMedGoogle Scholar
  3. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T (1993) Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 241:271–273CrossRefPubMedGoogle Scholar
  4. Gardiner SM, Kemp PA, March JE, Bennett T (1995) Regional haemodynamic effects of human and rat adrenomedullin in conscious rats. Br J Pharmacol 114:584–591PubMedGoogle Scholar
  5. Khan AI, Kato J, Kitamura K, Kangawa K, Eto T. (1997) Hypotensive effect of chronically infused adrenomedullin in conscious Wistar-Kyoto and spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 24:139–42.PubMedGoogle Scholar
  6. Khan AI, Kato J, Ishiyama Y, Kitamura K, Kangawa K, Eto T. (1997) Effect of chronically infused adrenomedullin in two-kidney, one-clip hypertensive rats. Eur J Pharmacol. 333:187–90.CrossRefPubMedGoogle Scholar
  7. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 192:553–60.CrossRefPubMedGoogle Scholar
  8. Lainchbury JG, Nicholls MG, Espiner EA, Yandle TG, Lewis LK, Richards AM. (1999) Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension. 34:70–5.PubMedGoogle Scholar
  9. McGregor DO, Troughton RW, Frampton C, Lynn KL, Yandle T, Richards AM, Nicholls MG. (2001) Hypotensive and natriuretic actions of adrenomedullin in subjects with chronic renal impairment. Hypertension. 37:1279–84.PubMedGoogle Scholar
  10. Miura K, Ebara T, Okumura M, Matsuura T, Kim S, Yukimura T, Iwao H (1995) Attenuation of adrenomedullin-induced renal vasodilatation by NG-nitro L-arginine but not glibenclamide. Br J Pharmacol 115:917–924PubMedGoogle Scholar
  11. Mori Y, Nishikimi T, Kobayashi N, Ono H, Kangawa K, Matsuoka H. (2002) Long-term adrenomedullin infusion improves survival in malignant hypertensive rats. Hypertension. 40: 107–13.CrossRefPubMedGoogle Scholar
  12. Nagaya N, Nishikimi T, Uematsu M, Nagaya N, Nishikimi T, Horio T, Yoshihara F, Kanazawa A, Matsuo H, Kangawa K. (1999) Cardiovascular and renal effects of adrenomedullin in rats with heart failure. Am J Physiol. 276:R213–8.PubMedGoogle Scholar
  13. Nagaya N, Nishikimi T, Uematsu M, Satoh T, Oya H, Kyotani S, Sakamaki F, Ueno K, Nakanishi N, Miyatake K, Kangawa K. (2000a) Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart. 84:653–8.CrossRefPubMedGoogle Scholar
  14. Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F, Oya H, Kyotani S, Nakanishi N, Goto Y, Masuda Y, Miyatake K, Kangawa K. (2000b) Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation. 101:498–503.PubMedGoogle Scholar
  15. Nagaya N, Okumura H, Uematsu M, Shimizu W, Ono F, Shirai M, Mori H, Miyatake K, Kangawa K. (2003) Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats. Am J Physiol Heart Circ Physiol. 285:H2125–31.PubMedGoogle Scholar
  16. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K (1997) Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 95:1214–1221PubMedGoogle Scholar
  17. Nishikimi T, Yoshihara F, Kanazawa A, Okano I, Horio T, Nagaya N, Yutani C, Matsuo H, Matsuoka H, Kangawa K. (2001) Role of increased circulating and renal adrenomedullin in rats with malignant hypertension. Am J Physiol Regul Integr Comp Physiol. 281:R2079–87.PubMedGoogle Scholar
  18. Nishikimi T, Mori Y, Kobayashi N, Tadokoro K, Wang X, Akimoto K, Yoshihara F, Kangawa K, Matsuoka H. (2002) Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension. 39:1077–82.CrossRefPubMedGoogle Scholar
  19. Nishikimi T, Yoshihara F, Horinaka S, Kobayashi N, Mori Y, Tadokoro K, Akimoto K, Minamino N, Kangawa K, Matsuoka H. (2003) Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to heart failure in rats. Hypertension. 42:1034–41.CrossRefPubMedGoogle Scholar
  20. Okumura H, Nagaya N, Itoh T, Okano I, Hino J, Mori K, Tsukamoto Y, Ishibashi-Ueda H, Miwa S, Tambara K, Toyokuni S, Yutani C, Kangawa K. (2004) Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the hosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation. 109:242–8.CrossRefPubMedGoogle Scholar
  21. Rademaker MT, Charles CJ, Lewis LK, Yandle TG, Cooper GJ, Coy DH, Richards AM, Nicholls MG. (1997) Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation. 96:1983–90.PubMedGoogle Scholar
  22. Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG, Richards AM. (2002a) Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure. Hypertension. 39:93–8.CrossRefPubMedGoogle Scholar
  23. Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM. (2002b) Long-term adrenomedullin administration in experimental heart failure. Hypertension. 40:667–72.CrossRefPubMedGoogle Scholar
  24. Parkes DG, May CN (1997) Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 120:1179–1185PubMedGoogle Scholar
  25. Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG.(2000) Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension. Hypertension. 36:588–93.PubMedGoogle Scholar
  26. Yoshihara F, Nishikimi T, Horio T, Yutani C, Takishita S, Matsuo H, Ohe T, Kangawa K. (1998) Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmacol. 355:33–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Toshio Nishikimi
    • 1
  • Noritoshi Nagaya
    • 2
  • Kenji Kangawa
    • 2
  • Hiroaki Matsuoka
    • 1
  1. 1.Department of Hypertension and Cardiorenal MedicineDokkyo University Medical SchoolTochigiJapan
  2. 2.National Cardiovascular Center Research InstituteOsakaJapan

Personalised recommendations